News
Multiomics blood test outperforms others for CRC
- Author:
- Susan London
SAN FRANCISCO - A multiomics test detected stage I and II colorectal cancer with 94% sensitivity and specificity, outperforming a fecal...
News
Hypofractionated radiotherapy for prostate cancer stands the test of time
- Author:
- Susan London
SAN FRANCISCO – An 8-year update of the CHHiP trial confirms that hypofractionated radiotherapy yields a noninferior rate of freedom from...
News
Subtype appears to predict docetaxel benefit in prostate cancer
- Author:
- Susan London
SAN FRANCISCO – Adding docetaxel to androgen deprivation therapy significantly improved overall survival among men with the luminal B subtype of...
News
Multiomics blood test outperforms other tests for colorectal cancer screening
- Author:
- Susan London
SAN FRANCISCO – A multiomics test detected stage I and II colorectal cancer with 94% sensitivity and specificity, outperforming a fecal...
News
Avelumab maintenance in gastric cancer is down but maybe not out
- Author:
- Susan London
SAN FRANCISCO – A trial pitting avelumab maintenance against continued chemotherapy was negative, but a flipping of the survival curves during...
News
Dual immunotherapy goes the distance in MSI-H colorectal cancer
- Author:
- Susan London
SAN FRANCISCO – At a median follow-up of almost 20 months, combination nivolumab and ipilimumab remained highly active as first-line therapy for...
News
Resecting primary tumors fails to boost survival in metastatic CRC
- Author:
- Susan London
SAN FRANCISCO – In the first randomized trial to report on this practice, median overall survival was about 2 years regardless of whether or not...
News
Cisplatin-gemcitabine is highly active in BRCA/PALB2+ pancreatic cancer
- Author:
- Susan London
SAN FRANCISCO – About two-thirds of patients had a response with combination cisplatin and gemcitabine, and adding the PARP inhibitor veliparib...
News
Sociodemographic disadvantage confers poorer survival in young adults with CRC
- Author:
- Susan London
SAN FRANCISCO – Patients with colorectal cancer aged 40 years or younger who lived in areas having low income and low educational attainment, or...
News
Blood test may advance diagnosis of GI cancers
- Author:
- Susan London
The Circulating Cell-free Genome Atlas (CCGA) study finds that a multicancer assay using targeted methylation sequencing of plasma cell-free DNA...
News
Dual HER2 therapy added to CRT for esophageal cancer is tolerable, active
- Author:
- Susan London
Addition of both trastuzumab and pertuzumab to neoadjuvant chemoradiotherapy for resectable HER2-positive esophageal adenocarcinoma is feasible...
News
Urothelial cancer: Less gained from immunotherapy in patients with poor performance scores
- Author:
- Susan London
Among patients given immune checkpoint inhibitors in the first-line setting, overall survival was more than twice as long for those with a good...
News
Standard-dose RT with concurrent chemo found superior for unresectable NSCLC
- Author:
- Susan London
An update of the RTOG 0617 trial, now at a median follow-up of 5.1 years, finds that overall survival is better with standard-dose RT versus high-...
News
Fertility-sparing surgery is safe for most with epithelial ovarian cancer
- Author:
- Susan London
Except among women with advanced serous tumors, surgery preserving the unaffected ovary and uterus was not associated with a significantly...
News
Sequential CRT, immunotherapy nets high PFS in node-positive cervical cancer
- Author:
- Susan London
More than four in five patients were alive and free of disease progression a year after receiving chemoradiotherapy followed by ipilimumab, and...